Biomarker-based score helps differentiate progressive from relapsing-remitting MS

New findings suggest that a score based on the ratio of levels of glial markers to the level of neurofilament light chain (NfL) in the cerebrospinal fluid (CSF) may help differentiate progressive MS (PMS) from relapsing-remitting MS (RRMS).